You beat me to it skhammer...SPL has been plodding along for years now. I've been in for about 5-6 years now and more than happy to just hold this one.
I'm expecting results to be good based on the stage 2 trial results. And that the current treatment for BV consists of antibiotics with poor results and many more side effects.
If these results are good, it paves the way for the stage 3 prevention trial which will be a bigger driver of share price .
The best thing about this company is the technology and its broad range of applications.
